Status:
UNKNOWN
Arthroscopic Treatment With Ulnar Nerve Release for Elbow Osteoarthritis
Lead Sponsor:
Beijing Jishuitan Hospital
Conditions:
Primary Osteoarthritis, Elbow
Ulnar Nerve Release
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a prospective randomized controlled study of arthroscopic release for primary osteoarthritis of the elbow with stiffness with or without ulnar nerve release. The patients with primary os...
Eligibility Criteria
Inclusion
- Age \>18 years
- Primary osteoarthritis of the elbow with stiffness. Osteoarthritis was confirmed on CT-arthrography, by cartilage damage, osteophytes or local or global joint impingement.
- Ulnar neuropathy proven by electromyography without clinical symptoms
- Failure at least 6 months of conservative treatment
- Availability of medical information for \>2 years of follow-up
Exclusion
- Severe skin contracture or wound problem that could affect the neurovascular structures or require flap surgery.
- Revision surgery
- Ulnar nerve pathology results in clinical symptom such as motion and feeling deficiency
- Other indication for elbow arthroscopy: synovial or inflammatory rheumatoid pathology, osteochondritis dissecan, acute infection, tumor or pure capsular stiffness.
- Inadequate or loss of follow-up
- elbow instability
Key Trial Info
Start Date :
January 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05184010
Start Date
January 30 2022
End Date
December 30 2024
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Jishuitan hospital
Beijing, Beijing Municipality, China, 100000